View in EDS

Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 study.

Saved in:
Bibliographic Details
Title: Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 study.
Authors: Frenck RW Jr; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, OH, USA. Electronic address: robert.frenck@cchmc.org., Naficy A; PATH, Seattle, WA, USA., Feser J; PATH, Seattle, WA, USA., Dickey MP; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, OH, USA., Leyva-Grado VH; Auro Vaccines, Pearl River, NY, USA., Egan MA; Auro Vaccines, Pearl River, NY, USA., Chen T; Auro Vaccines, Pearl River, NY, USA., Eldridge JH; Auro Vaccines, Pearl River, NY, USA., Sciotto-Brown S; Auro Vaccines, Pearl River, NY, USA., Hermida L; Auro Vaccines, Pearl River, NY, USA., Promeneur D; Auro Vaccines, Pearl River, NY, USA., Luckay A; Auro Vaccines, Pearl River, NY, USA., Medina H; Auro Vaccines, Pearl River, NY, USA., Lazaro GA; Auro Vaccines, Pearl River, NY, USA., Patel NR; Auro Vaccines, Pearl River, NY, USA., Naqvi T; Auro Vaccines, Pearl River, NY, USA., Broder CC; Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA., Dimitrov AS; Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA; Henry M Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, USA., Gast C; PATH, Seattle, WA, USA., Mercer LD; PATH, Seattle, WA, USA., Raine M; PATH, Seattle, WA, USA., Andi-Lolo I; PATH, Seattle, WA, USA., Innis BL; PATH, Seattle, WA, USA., Aponte JJ; PATH, Seattle, WA, USA., Hamm S; Auro Vaccines, Pearl River, NY, USA., Rathi N; PATH, India.
Source: Lancet (London, England) [Lancet] 2025 Dec 13; Vol. 406 (10521), pp. 2792-2803. Date of Electronic Publication: 2025 Nov 14.
Publication Type: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41248666
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Frenck+RW+Jr%22">Frenck RW Jr</searchLink>; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, OH, USA. Electronic address: robert.frenck@cchmc.org.<br /><searchLink fieldCode="AU" term="%22Naficy+A%22">Naficy A</searchLink>; PATH, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Feser+J%22">Feser J</searchLink>; PATH, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Dickey+MP%22">Dickey MP</searchLink>; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Leyva-Grado+VH%22">Leyva-Grado VH</searchLink>; Auro Vaccines, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Egan+MA%22">Egan MA</searchLink>; Auro Vaccines, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Chen+T%22">Chen T</searchLink>; Auro Vaccines, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Eldridge+JH%22">Eldridge JH</searchLink>; Auro Vaccines, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Sciotto-Brown+S%22">Sciotto-Brown S</searchLink>; Auro Vaccines, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hermida+L%22">Hermida L</searchLink>; Auro Vaccines, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Promeneur+D%22">Promeneur D</searchLink>; Auro Vaccines, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Luckay+A%22">Luckay A</searchLink>; Auro Vaccines, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Medina+H%22">Medina H</searchLink>; Auro Vaccines, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lazaro+GA%22">Lazaro GA</searchLink>; Auro Vaccines, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Patel+NR%22">Patel NR</searchLink>; Auro Vaccines, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Naqvi+T%22">Naqvi T</searchLink>; Auro Vaccines, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Broder+CC%22">Broder CC</searchLink>; Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Dimitrov+AS%22">Dimitrov AS</searchLink>; Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA; Henry M Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Gast+C%22">Gast C</searchLink>; PATH, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Mercer+LD%22">Mercer LD</searchLink>; PATH, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Raine+M%22">Raine M</searchLink>; PATH, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Andi-Lolo+I%22">Andi-Lolo I</searchLink>; PATH, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Innis+BL%22">Innis BL</searchLink>; PATH, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Aponte+JJ%22">Aponte JJ</searchLink>; PATH, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Hamm+S%22">Hamm S</searchLink>; Auro Vaccines, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Rathi+N%22">Rathi N</searchLink>; PATH, India.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2025 Dec 13; Vol. 406 (10521), pp. 2792-2803. <i>Date of Electronic Publication: </i>2025 Nov 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41248666
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S0140-6736(25)01390-X
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2792
    Titles:
      – TitleFull: Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Frenck RW Jr
      – PersonEntity:
          Name:
            NameFull: Naficy A
      – PersonEntity:
          Name:
            NameFull: Feser J
      – PersonEntity:
          Name:
            NameFull: Dickey MP
      – PersonEntity:
          Name:
            NameFull: Leyva-Grado VH
      – PersonEntity:
          Name:
            NameFull: Egan MA
      – PersonEntity:
          Name:
            NameFull: Chen T
      – PersonEntity:
          Name:
            NameFull: Eldridge JH
      – PersonEntity:
          Name:
            NameFull: Sciotto-Brown S
      – PersonEntity:
          Name:
            NameFull: Hermida L
      – PersonEntity:
          Name:
            NameFull: Promeneur D
      – PersonEntity:
          Name:
            NameFull: Luckay A
      – PersonEntity:
          Name:
            NameFull: Medina H
      – PersonEntity:
          Name:
            NameFull: Lazaro GA
      – PersonEntity:
          Name:
            NameFull: Patel NR
      – PersonEntity:
          Name:
            NameFull: Naqvi T
      – PersonEntity:
          Name:
            NameFull: Broder CC
      – PersonEntity:
          Name:
            NameFull: Dimitrov AS
      – PersonEntity:
          Name:
            NameFull: Gast C
      – PersonEntity:
          Name:
            NameFull: Mercer LD
      – PersonEntity:
          Name:
            NameFull: Raine M
      – PersonEntity:
          Name:
            NameFull: Andi-Lolo I
      – PersonEntity:
          Name:
            NameFull: Innis BL
      – PersonEntity:
          Name:
            NameFull: Aponte JJ
      – PersonEntity:
          Name:
            NameFull: Hamm S
      – PersonEntity:
          Name:
            NameFull: Rathi N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 12
              Text: 2025 Dec 13
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1474-547X
          Numbering:
            – Type: volume
              Value: 406
            – Type: issue
              Value: 10521
          Titles:
            – TitleFull: Lancet (London, England)
              Type: main
ResultId 1